Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 99% | 5542.31 | 169 / 170 | 99% | 27.64 | 454 / 459 |
bladder | 100% | 4204.57 | 21 / 21 | 98% | 24.10 | 493 / 504 |
breast | 100% | 8059.70 | 457 / 459 | 98% | 40.73 | 1098 / 1118 |
lung | 99% | 9635.49 | 574 / 578 | 98% | 26.66 | 1137 / 1155 |
prostate | 98% | 5630.47 | 241 / 245 | 95% | 24.41 | 478 / 502 |
intestine | 92% | 4353.77 | 888 / 966 | 99% | 28.03 | 520 / 527 |
thymus | 91% | 2928.30 | 591 / 653 | 96% | 21.69 | 579 / 605 |
liver | 92% | 2070.52 | 209 / 226 | 93% | 20.81 | 379 / 406 |
esophagus | 78% | 3888.84 | 1132 / 1445 | 99% | 25.76 | 181 / 183 |
ovary | 73% | 2006.41 | 131 / 180 | 98% | 19.82 | 420 / 430 |
stomach | 63% | 2587.62 | 227 / 359 | 99% | 26.40 | 282 / 286 |
kidney | 69% | 1660.89 | 61 / 89 | 90% | 23.31 | 814 / 901 |
skin | 60% | 1534.41 | 1085 / 1809 | 99% | 33.06 | 466 / 472 |
brain | 37% | 851.35 | 983 / 2642 | 100% | 33.38 | 704 / 705 |
pancreas | 13% | 216.17 | 44 / 328 | 96% | 29.58 | 171 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 57.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 107.62 | 29 / 29 |
spleen | 100% | 5224.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.21 | 1 / 1 |
peripheral blood | 100% | 12600.32 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10939.98 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 5994.81 | 1195 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 666.59 | 76 / 258 | 61% | 10.39 | 140 / 230 |
heart | 86% | 3453.49 | 739 / 861 | 0% | 0 | 0 / 0 |
muscle | 71% | 2254.55 | 568 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901985 | Biological process | positive regulation of protein acetylation |
GO_2000556 | Biological process | positive regulation of T-helper 1 cell cytokine production |
GO_0045087 | Biological process | innate immune response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000318 | Biological process | positive regulation of T-helper 17 type immune response |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0003677 | Molecular function | DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0035613 | Molecular function | RNA stem-loop binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ARID5A |
Protein name | AT-rich interaction domain 5A AT-rich interactive domain-containing protein 5A (ARID domain-containing protein 5A) (Modulator recognition factor 1) (MRF-1) |
Synonyms | MRF1 |
Description | FUNCTION: Binds to AT-rich stretches in the modulator region upstream of the human cytomegalovirus major intermediate early gene enhancer. May act as repressor and down-regulate enhancer-dependent gene expressison . May positively regulate chondrocyte-specific transcription such as of COL2A1 in collaboration with SOX9 and positively regulate histone H3 acetylation at chondrocyte-specific genes. May stimulate early-stage chondrocyte differentiation and inhibit later stage differention (By similarity). Can repress ESR1-mediated transcriptional activation; proposed to act as corepressor for selective nuclear hormone receptors . As RNA-binding protein involved in the regulation of inflammatory response by stabilizing selective inflammation-related mRNAs, such as IL6, STAT3 and TBX21. Binds to stem loop structures located in the 3'UTRs of IL6, STAT3 and TBX21 mRNAs; at least for STAT3 prevents binding of ZC3H12A to the mRNA stem loop structure thus inhibiting its degradation activity. Contributes to elevated IL6 levels possibly implicated in autoimmunity processes. IL6-dependent stabilization of STAT3 mRNA may promote differentiation of naive CD4+ T-cells into T-helper Th17 cells. In CD4+ T-cells may also inhibit RORC-induced Th17 cell differentiation independently of IL6 signaling. Stabilization of TBX21 mRNA contributes to elevated interferon-gamma secretion in Th1 cells possibly implicated in the establishment of septic shock (By similarity). Stabilizes TNFRSF4/OX40 mRNA by binding to the conserved stem loop structure in its 3'UTR; thereby competing with the mRNA-destabilizing functions of RC3H1 and endoribonuclease ZC3H12A (By similarity). . |
Accessions | ENST00000357485.8 [Q03989-1] F6Q9D3 ENST00000454558.2 [Q03989-5] ENST00000412735.5 A0A669KBH0 Q03989 ENST00000673792.1 |